Experimental Diabetes ResearchVolume 2012 (2012), Article ID 973561, 5 pagesdoi:10.1155/2012/973561

Clinical Study

ADRB3 Polymorphism Associated with BMI Gain in Japanese Men

Shouhei Takeuchi,¹ Takahiko Katoh,² Takenori Yamauchi,¹ and Yoshiki Kuroda¹

¹Department of Public Health, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan²Department of Public Health, Faculty of Life Sciences, Kumamoto University, 1-1-1 Honjou, Kumamoto 860-8556, Japan

Received 11 November 2011; Revised 21 January 2012; Accepted 3 February 2012

Academic Editor: Toshiyasu Sasaoka

Copyright © 2012 Shouhei Takeuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. The aim of this study was to evaluate the association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene (ADRB3: rs4994) and BMI and serological and anthropometric data in healthy Japanese. Methods. Healthy Japanese recruited in a large-scale integrated manufacturing facility in Japan (; age: 37.25 ± 9.43; BMI: 22.86 ± 3.46) were eligible for analysis. The anthropometric data and serological data were measured during a comprehensive health check, and a self-reporting questionnaire was used to assess lifestyle habits (current exercise, smoking status, alcohol intake, and working style) and weight at age 20. Genotyping for the ADRB3 polymorphism was performed by PCR-RFLP method. Results. Among 1355 participants, the genotype frequencies of the Trp/Trp, Trp/Arg, and Arg/Arg variants were 920 (67.9%), 394 (29.1%), and 41 (3.05%), respectively. In the multivariate analysis, a multiple linear regression model in men for the adjustment of age, drinking habits, smoking habits, exercise habits, working status and serological measurements statistically showed an overall weak significance between annual BMI gain from age 20 and age, LDL or ADRB3 polymorphism. Conclusions. The level of LDL, age, and ADRB3 polymorphism (Arg/Arg genotype) were statistically associated with annual BMI gain in Japanese men.

1. Introduction

The beta3-adrenergic receptor (ADRB3) is primarily expressed in adipose tissue [1] and is involved in the regulation of energy metabolism. In 1995, three reports related to the polymorphism of ADRB3 in codon 64 (Trp64Arg: rs4994) were published. They reported that early development of type 2 diabetes mellitus, lower resting metabolic rate, abdominal obesity, and resistance to insulin were associated with persons homozygous for the variant allele (Arg/Arg) compared to those homozygous for the wild-type allele (Trp/Trp) and those heterozygous for the variant allele (Trp/Arg) [2–6]. Piétri-Rouxel et al. showed that in human HEK293 cells with ADRB3 variant allele, the reduction in cAMP accumulation in response to beta3-adrenergic agonists resulted in decreased lipolysis and thermogenesis [7]. Umekawa et al. also showed that ADRB3 variant was associated with lower lipolytic activities in human omental adipocytes [8]. Therefore, an impairment of ADRB3 may lead to obesity through the energy expenditure reduction of fat tissue. This allowed us to accept ADRB3 as a candidate gene for obesity [9, 10].

However, the association between BMI gain and the ADRB3 polymorphism is still controversial. The meta-analyses indicated that there was an association between BMI and the ADRB3 polymorphism among an obese population [11] and among obese and normal populations [12]. Conversely, several studies [13, 14] suggested that there was no association between BMI and the ADRB3 polymorphism. The aim of this study was to evaluate the influence of ADRB3 polymorphism on BMI and serological and anthropometric data in healthy Japanese.

2. Subjects and Methods

2.1. Subjects

The participants were recruited from employees working at a large-scale integrated manufacturing facility in Japan, and their routine medical checkup data were used for the analysis. Of the 1401 participants, only the workers who were out of work or who had serious symptoms were excluded from this study, 1355 agreed to participate in the present study with informed consent, 1074 (77%) were males and 284 (20%) were females. We analyzed the ADRB3 polymorphism, lifestyle habits, and anthropometric data (2 men and a woman had missing data) for the participants. Their ages ranged from 18 to 65 years (mean: years). During a comprehensive health check, the following anthropometric data and serological data were measured: height, weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), GOT, GPT, γ-GTP, total cholesterol, low-density lipoprotein cholesterol (LDL) and high-density lipoprotein cholesterol (HDL), and triglyceride. For the lifestyle assessment, current exercise (no, 1-2 days/week, or 3–7 days/week), smoking status (no, 1–20 cigarettes/day, or more than 20 cigarettes/day), alcohol intake (no, sometimes, or every day), working style (having night shift or not), and weight at age 20 were obtained through a self-reporting questionnaire. Body mass index (BMI) was calculated as weight (in kilograms) divided by height (in meters) squared. We followed the Ethical Guideline for Human Genome/Gene Analysis Research endorsed by the Japanese government. The study protocol was approved by the ethics committee of University of Miyazaki Graduate School of Medical Sciences, and all subjects provided written informed consent.

2.2. Genotyping

Genomic DNA was extracted from peripheral blood leukocytes by using a DNA Extractor WB Kit (Wako Pure Chemical Industries, Osaka, Japan). Amplification of DNA by polymerase chain reaction was carried out to analyze for the Trp64Arg polymorphism with the primer (sense: 5′-CGCCCAATACCGCCAACAC-3′, antisense: 5′-CCACCAGGAGTCCCATCACC-3′) under the same procedure described by Widen et al. with the restriction enzyme Mva I [4]. The amplified fragments of 210 bp were digested with Mva I and analyzed by 3% agarose-gel electrophoresis. The fragment size was judged as the Arg/Arg type if 161 base pairs; the Trp/Trp type if 99 and 62 base pairs; the Trp/Arg type if 161, 99, and 62 base pairs.

2.3. Statistical Analysis

Results are presented as mean ± standard deviation (SD), and categorical variables are expressed as numbers counted. All analyses were performed stratified by sex due to the difference in number of male and female participants. The exact test was used to verify Hardy-Weinberg equilibrium of genotype frequencies. The analysis of variance (ANOVA) or Kruskal-Wallis rank sum test was used to access the differences among ADRB3 gene polymorphism. Multivariate analysis for adjusting age, sex, current exercise, alcohol intake, working style, and smoking habits was performed by multiple linear regression analysis. The level of statistical significance was set at . All analyses were performed using R version 2.12.2.

3. Results

Genotyping of the ADRB3 polymorphism in the 1355 participants showed that those homozygous for the wild-type allele (Trp/Trp) were 920 (67.9%), those heterozygous for the variant allele (Arg/Trp) were 394 (29.1%), and those homozygous for the variant allele (Arg/Arg) were 41 (3.0%). These results were in the Hardy-Weinberg equilibrium and did not conflict with the results previously reported in another Japanese population ().

The demographic characteristics and lifestyle habits of the participants stratified by the genotype of the ADRB3 polymorphism are presented in Table 1. Among all participants, the mean age was (mean ± SD) and the mean BMI was (mean ± SD). There were no significant differences with age and BMI in each stratified group. We also divided participant data into categories based on sex, smoking status, current exercise, and working style. In each category, the distributions of the genotypes were not different from the results previously reported in another Japanese population.

Table 1: Sociodemographic information and lifestyle habits stratified by ADRB3 polymorphism.

Trp64Trp
Trp64Arg
Arg64Arg

N

920
394
41

Age

Sex
Male
719
320
33

Female
201
74
8

BMI (kg/m²)

Smoking status
No
450
191
15

≦20 cigarettes
381
172
20

≧21 cigarettes
89
31
6

Current exercise
No
591
217
25

1-2 days/week
261
144
12

3–7 days/week
68
33
4

Working style
Having shift work
489
211
25

Not having shift work
431
183
16

All variables did not associate with the ADRB3 polymorphism.

The serological test results of the participants are shown in Table 2. There was no association between these serological results and the genotype of the ADRB3 polymorphism (ANOVA and Kruskal-Wallis rank sum test).

Table 2: Serological variables stratified by the ADRB3 polymorphism.

Trp64Trp
Trp64Arg
Arg64Arg

SBP (mmHg)

DBP (mmHg)

GOT (IU/l)

GPT (IU/l)

LDL (mg/dL)

HDL (mg/dL)

TG (mg/dL)

No significant difference among the ADRB3 polymorphism was found in each serological variable.

A multiple linear regression model for the adjustment of age, sex, alcohol intake, smoking status, current exercise, working status, LDL, and ADRB3 polymorphism (Table 3) showed an overall weak model for predicting annual BMI gain (the degree of BMI increase) from age 20 per year by age, smoking status, LDL, and Arg/Arg genotype. To avoid the bias caused by the difference in number of male and female participants, data were stratified by sex and analyzed separately. There were statistically significant associations in male between the genotype of the ADRB3 polymorphism, age, and LDL and the annual BMI gain (Table 4), and there was no statistically significant association in female (Table 5).

Table 3: Multiple regression analysis for annual BMI gain and variables.

Estimate
SE
value
Pr

Intercept
0.171
0.096
1.788
0.075

Age
−0.000
0.000
−2.241
0.026*

Sex
0.014
0.060
0.233
0.816

Alcohol intake
0.000
0.000
−0.286
0.776

Current exercise
−0.000
0.028
−0.338
0.736

Working style
0.013
0.037
0.359
0.720

Smoking status
−0.057
0.028
−2.053
0.041*

ADRB3 (Trp/Arg)
−0.000
0.037
−0.078
0.938

ADRB3 (Arg/Arg)
0.216
0.082
2.626
0.009**

LDL
0.000
0.000
3.449
<0.001**

From the stepwise multiple regression analysis, age, sex, alcohol intake, current exercise, working style, smoking status, LDL, and the ADRB3 polymorphism were selected for the final model of the predictor of BMI gain, adjusted (F-statistic = 2.874, ).

Table 4: Multiple regression analysis for annual BMI gain and variables in Japanese men.

Estimate
SE
value
Pr

Intercept
0.193
0.097
1.998
0.047*

Age
−0.005
0.002
−2.326
0.021*

Alcohol intake
0.000
0.000
−0.649
0.517

Current exercise
0.002
0.027
0.067
0.947

Working style
0.001
0.038
0.015
0.988

Smoking status
−0.053
0.028
−1.883
0.061

ADRB3 (Trp/Arg)
0.009
0.038
0.227
0.821

ADRB3 (Arg/Arg)
0.218
0.079
2.761
0.006**

LDL
0.002
0.001
3.245
0.001**

From the stepwise multiple regression analysis, age, alcohol intake, current exercise, working style, smoking status, LDL, and the ADRB3 polymorphism were selected for the final model of the predictor of BMI gain, adjusted (F-statistic = 3.224, ).

Table 5: Multiple regression analysis for annual BMI gain and variables in Japanese women.

Estimate
SE
value
Pr

Intercept
−0.421
0.474
−0.888
0.392

Age
0.004
0.012
0.363
0.723

Alcohol intake
0.000
0.000
0.486
0.636

Current exercise
−0.357
0.263
−1.356
0.200

Working style
0.147
0.153
0.958
0.357

Smoking status
0.057
0.183
0.309
0.763

ADRB3 (Trp/Arg)
0.127
0.256
0.497
0.628

LDL
0.005
0.003
1.746
0.106

From the stepwise multiple regression analysis, age, alcohol intake, current exercise, working style, smoking status, LDL, and the ADRB3 polymorphism were selected for the final model of the predictor of BMI gain, adjusted (F-statistic , ).

4. Discussion

The effects of ADRB3 polymorphism were reported in 1995 [2–4]. The potential for weight gain among the population having the Trp/Arg mutation of the ADRB3 gene has been suggested [2]. It was thought that the variant allele (Arg/Arg) had lower lipolytic activities and induced heavier weight [15]. In the present study, we analyzed the relationship between annual BMI gain and the ADRB3 polymorphism in Japanese young men who are generally healthy. In the multivariate analysis, the ADRB3 genotype (Arg/Arg), age, and LDL were associated with annual BMI gain. This result indicated that the annual BMI gain was increased with Arg/Arg genotype compared to Trp/Trp genotype, and high LDL was also related to increased annual BMI gain. The high LDL, however, could not be thought to be the cause of the annual BMI gain. Therefore, the high LDL was thought to be a result of increased body weight.

On the other hand, our results indicated that the ADRB3 polymorphism was not associated with current BMI. The relationship between the ADRB3 polymorphism and current BMI has been controversial. Shiwaku et al. [16], Tahara et al. [17], Witchel et al. [18], and Matsushita et al. [14] reported that the ADRB3 polymorphism and BMI have not associated significantly with each other. Conversely, Oizumi et al. [15] pointed out that the Arg/Arg genotype was associated with obesity and current BMI. There were meta-analysis studies concerning the ADRB3 polymorphism and obesity [11, 12] which indicated that Arg/Arg genotype led to increased body weight. These previous studies seem to lead the hypothesis that the ADRB3 polymorphism is associated with current BMI and suggest that the ADRB3 polymorphism could be a genetic predictor of increased body weight. However, there still have been confounding factors that induced obesity and overweight such as lack of exercise, over intake of energy, and predisposition of other genes. These confounders could be one reason why the relationship between the ADRB3 polymorphism and BMI is still controversial.

While Matsuo et al. [19] indicated that BMI for older adults (60–79-year-age group) was higher than that of middle-aged adults (40–59-year-age group), other reports showed that BMI gain is more severe in middle age than old age [20–22]. Berg et al. [20] indicated that the largest increases in obesity and overweight were in young people. On the other hand, the effects of genetic predisposition on difference in body weight might exist to a greater extent among middle aged than older adults [23]. The present study also indicated that annual BMI gain was greater with Arg/Arg genotype compared to Trp/Trp in younger men (the mean age was ). Matsushita et al. [14] suggested little or no influence of the ADRB3 polymorphism on BMI gain in their report. However their mean age was older than that of the present study. BMI gain (the degree of BMI increase) might be thought to be more suitable to evaluate the relation between the ADRB3 polymorphism and body weight influence, and the time for evaluation of BMI gain related to the ADRB3 polymorphism was more suitable in the younger group.

In the present study, we had some limitations. One of them was that our data might include the information bias because we used the questionnaire to get the weight at age 20. We believed that the body weights in the questionnaire were not so different from true weight at age 20 because many people can remember their weight at age 20. However, caution was needed in evaluating this data for female participants, as women tended to reply lighter weight. Another was the lack of checking the plasma glucose, HbA1c, and fasting insulin data, even NIDDM was discussed in this article.

Obesity and overweight are associated with incidence of diabetes. The Trp/Arg genotype of the ADRB3 polymorphism has been said to be associated with resistance to insulin and may contribute to the early onset of NIDDM [3, 4]. We have not evaluated the relationship between the incidence of diabetes and the ADRB3 polymorphism. Considering that Sasai et al. [24] showed that the effects of BMI on diabetes mellitus are greater among middle-aged than older adults, and the present result also suggests that the Arg/Arg genotype of ADRB3 polymorphism might be a risk factor for diabetes.

We also have not evaluated the effects of exercise in relation to the ADRB3 polymorphism. The relationship between the ADRB3 polymorphism and BMI change (gain or reduction) with health programs, including training or exercise, has been controversial as well. The resistance to BMI reduction in those who had the variant allele of ADRB3 after exercise or training was suggested by the ratio of visceral to subcutaneous fat area after a 3-month weight reduction intervention among women in their 40s and 50s [25]. However, no resistance to BMI reduction in peoples who had the variant allele of ADRB3 was reported [17, 26–28]. As an important theme regarding the ADRB3 polymorphism, further investigation into the relationship between ADRB3 and the effects of exercise on obesity is warranted.

5. Conclusion

In conclusion, ADRB3 polymorphism and high levels of LDL were associated with annual BMI gain in men. On the other hand, the present study did not indicate the same relationship with ADRB3 polymorphism in women. Further studies are needed to clarify the underlying mechanism between the ADRB3 polymorphism and annual BMI gain and to evaluate the relationship between the effect of exercise and the ADRB3 polymorphism.

Acknowledgments

The authors would like to thank the persons who were involved in the organization of the study and all the participants of the study.

References

S. Krief, F. Lonnqvist, S. Raimbault et al., “Tissue distribution of β3-adrenergic receptor mRNA in man,” Journal of Clinical Investigation, vol. 91, no. 1, pp. 344–349, 1993.

K. Clement, C. Vaisse, B. S. J. Manning et al., “Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity,” New England Journal of Medicine, vol. 333, no. 6, pp. 352–354, 1995.

J. Walston, K. Silver, C. Bogardus et al., “Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the β3-adrenergic-receptor gene,” New England Journal of Medicine, vol. 333, no. 6, pp. 343–347, 1995.

E. Widen, M. Lehto, T. Kanninen, J. Walston, A. R. Shuldiner, and L. C. Groop, “Association of a polymorphism in the β3-adrenergic-receptor gene with features of the insulin resistance syndrome in finns,” New England Journal of Medicine, vol. 333, no. 6, pp. 348–351, 1995.

D. Corella, M. Guillén, O. Portolés et al., “Gender specific associations of the Trp64Arg mutation in the β3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation,” Journal of Internal Medicine, vol. 250, no. 4, pp. 348–360, 2001.

K. Hao, S. Peng, H. Xing et al., “β3 adrenergic receptor polymorphism and obesity-related phenotypes in hypertensive patients,” Obesity Research, vol. 12, no. 1, pp. 125–130, 2004.

F. Piétri-Rouxel, B. St John Manning, J. Gros, and A. D. Strosberg, “The biochemical effect of the naturally occurring Trp64→Arg mutation on human β3-adrenoceptor activity,” European Journal of Biochemistry, vol. 247, no. 3, pp. 1174–1179, 1997.

T. Umekawa, T. Yoshida, N. Sakane, A. Kogure, M. Kondo, and H. Honjyo, “Trp64Arg mutation of β3-adrenoceptor gene deteriorates lipolysis induced by β3-adrenoceptor agonist in human omental adipocytes,” Diabetes, vol. 48, no. 1, pp. 117–120, 1999.

T. Rankinen, A. Zuberi, Y. C. Chagnon et al., “The human obesity gene map: the 2005 update,” Obesity, vol. 14, no. 4, pp. 529–644, 2006.

K. Miyaki, S. Sutani, H. Kikuchi et al., “Increased risk of obesity resulting from the interaction between high energy intake and the Trp64Arg polymorphism of the β3-adrenergic receptor gene in healthy Japanese men,” Journal of Epidemiology, vol. 15, no. 6, pp. 203–210, 2005.

N. Kurokawa, K. Nakai, S. Kameo, Z. M. Liu, and H. Satoh, “Association of BMI with the β3-Adrenergic receptor gene polymorphism in Japanese: meta-analysis,” Obesity Research, vol. 9, no. 12, pp. 741–745, 2001.

T. Fujisawa, H. Ikegami, Y. Kawaguchi, and T. Ogihara, “Meta-analysis of the association of Trp64 arg polymorphism of β3- adrenergic receptor gene with body mass index,” Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 7, pp. 2441–2444, 1998.

J. Gagnon, P. Mauriège, S. Roy et al., “The Trp64Arg mutation of the β3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts,” Journal of Clinical Investigation, vol. 98, no. 9, pp. 2086–2093, 1996.

Y. Matsushita, T. Yokoyama, N. Yoshiike et al., “The Trp64Arg polymorphism of the β3-adrenergic receptor gene is not associated with body weight or body mass index in Japanese: a longitudinal analysis,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 12, pp. 5914–5920, 2003.

T. Oizumi, M. Daimon, T. Saitoh et al., “Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the β3-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample,” Diabetes Care, vol. 24, no. 9, pp. 1579–1583, 2001.

K. Shiwaku, A. Nogi, E. Anuurad et al., “Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the β3-adrenergic receptor gene,” International Journal of Obesity, vol. 27, no. 9, pp. 1028–1036, 2003.

A. Tahara, Y. Osaki, and T. Kishimoto, “Effect of the β3-adrenergic receptor gene polymorphism Trp64Arg on BMI reduction associated with an exercise-based intervention program in Japanese middle-aged males,” Environmental Health and Preventive Medicine, vol. 15, no. 6, pp. 392–397, 2010.

S. F. Witchel, J. Fagerli, J. Siegel et al., “No association between body mass index and β3-adrenergic receptor variant (W64R) in children with premature pubarche and adolescent girls with hyperandrogenism,” Fertility and Sterility, vol. 73, no. 3, pp. 509–515, 2000.

T. Matsuo, T. Sairenchi, H. Iso et al., “Age- and gender-specific BMI in terms of the lowest mortality in Japanese general population,” Obesity, vol. 16, no. 10, pp. 2348–2355, 2008.

C. Berg, A. Rosengren, N. Aires et al., “Trends in overweight and obesity from 1985 to 2002 in Göteborg, West Sweden,” International Journal of Obesity, vol. 29, no. 8, pp. 916–924, 2005.

A. Cook and B. Daponte, “A demographic analysis of the rise in the prevalence of the US population overweight and/or obese,” Population Research and Policy Review, vol. 27, no. 4, pp. 403–426, 2008.

D. Howel, “Trends in the prevalence of obesity and overweight in English adults by age and birth cohort, 1991–2006,” Public Health Nutrition, vol. 14, no. 1, pp. 27–33, 2011.

A. J. Stunkard, T. I. A. Sorensen, and G. Hanis, “An adoption study of human obesity,” New England Journal of Medicine, vol. 314, no. 4, pp. 193–198, 1986.

H. Sasai, T. Sairenchi, H. Iso et al., “Relationship between obesity and incident diabetes in middle-aged and older Japanese adults: the Ibaraki prefectural health study,” Mayo Clinic Proceedings, vol. 85, no. 1, pp. 36–40, 2010.

M. Nakamura, M. Tanaka, S. Abe et al., “Association between beta 3-adrenergic receptor polymorphism and a lower reduction in the ratio of visceral fat to subcutaneous fat area during weight loss in Japanese obese women,” Nutrition Research, vol. 20, no. 1, pp. 25–34, 2000.

T. Kahara, T. Takamura, T. Hayakawa et al., “Prediction of exercise-mediated changes in metabolic markers by gene polymorphism,” Diabetes Research and Clinical Practice, vol. 57, no. 2, pp. 105–110, 2002.

S. Kuriyama, T. Shimazu, A. Hozawa et al., “No effect of the Trp64Arg variant of the β3-adrenergic receptor gene on weight loss by diet and exercise intervention among Japanese adults,” Metabolism, vol. 57, no. 11, pp. 1570–1575, 2008.

E. Morita, H. Taniguchi, and M. Sakaue, “Trp64Arg polymorphism in beta3-adrenergic receptor gene is associated with decreased fat oxidation both in resting and aerobic exercise in the Japanese male,” Experimental Diabetes Research, vol. 2009, Article ID 605139, 5 pages, 2009.